ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Voorhees, 90, died on June 3, 2015, in Pasadena, Calif.
“For more than 25 years, Bert worked with GE, first managing teams developing equipment for nuclear power systems; then overseeing one of GE’s aerospace projects, which sought to develop nuclear reactors as power sources for spacecraft; and finally managing GE’s Medical Ventures Operation. In 1975, he became vice president and general manager of analytical systems in Abbott Laboratories’ diagnostics division. In 1978, he became VP and GM of Becton, Dickinson & Co.’s fluorescence-activated cell sorter division, where his team developed the first commercially available FACS instrument, which revolutionized cell-based research, diagnostics, and treatment.”—Bert Voorhees, son
Most recent title: president and chief operating officer, Microgenics Corp.
Education: B.S., chemical engineering, Iowa State University, 1948
Survivors: daughter, Barb; sons, Bert and Dick; and six grandchildren
To recognize your late loved one or colleague, submit obituary information at cenm.ag/obits.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X